Compounds > 2-mercaptoethylguanidine
Page last updated: 2024-10-30

2-mercaptoethylguanidine and Acute Lymphoid Leukemia

2-mercaptoethylguanidine has been researched along with Acute Lymphoid Leukemia in 1 studies

2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kellner, C1
Zunino, SJ1

Other Studies

1 other study available for 2-mercaptoethylguanidine and Acute Lymphoid Leukemia

ArticleYear
Nitric oxide is synthesized in acute leukemia cells after exposure to phenolic antioxidants and initially protects against mitochondrial membrane depolarization.
    Cancer letters, 2004, Nov-08, Volume: 215, Issue:1

    Topics: Abietanes; Antioxidants; Curcumin; Enzyme Inhibitors; Guanidines; Humans; Intracellular Membranes; M

2004